Thomas M. Moriarty - 15 Mar 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP & General Counsel
Signature
/s/ Thomas M. Moriarty
Issuer symbol
CVS
Transactions as of
15 Mar 2022
Net transactions value
-$140,729
Form type
4
Filing time
17 Mar 2022, 16:32:03 UTC
Previous filing
23 Feb 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Sale $5,392,905 -51,361 -5.8% $105.00 836,751 15 Mar 2022 Direct
transaction CVS Common Stock Options Exercise $5,252,176 +51,361 +6.1% $102.26 888,112 15 Mar 2022 Direct F1
holding CVS Common Stock 81,179 15 Mar 2022 By GRAT
holding CVS Common Stock (restricted) 8,008 15 Mar 2022 Direct
holding CVS Stock Unit 46,519 15 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -51,361 -100% $0.000000* 0 15 Mar 2022 Common Stock 51,361 $102.26 Direct F1, F2
holding CVS Stock Option 71,696 15 Mar 2022 Common Stock 71,696 $104.82 Direct F3
holding CVS Stock Option 125,224 15 Mar 2022 Common Stock 125,224 $78.05 Direct F4
holding CVS Stock Option 36,490 15 Mar 2022 Common Stock 36,490 $62.21 Direct F5
holding CVS Stock Option 101,004 15 Mar 2022 Common Stock 101,004 $54.19 Direct F6
holding CVS Stock Option 147,837 15 Mar 2022 Common Stock 147,837 $58.34 Direct F7, F8
holding CVS Stock Option 155,495 15 Mar 2022 Common Stock 155,495 $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal installments, commencing 4/1/2022.